Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Venrock Healthcare Capital Partners II, L.P. | 3,867,749 9.300% | -197,251 (-4.85%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Provention Bio, Inc. PRVB | Venrock Healthcare Capital Partners II, L.P. | 1,118,653 1.300% | -2,725,143 (-70.90%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Venrock Healthcare Capital Partners II, L.P. | 1,770,705 3.700% | -1,109,391 (-38.52%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | Venrock Healthcare Capital Partners II, L.P. | 4,929,000 9.990% | 3,000,523 (+155.59%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% | 696,624 (+24.70%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | aTyr Pharma, Inc. ATYR | Venrock Healthcare Capital Partners II, L.P. | 1,171,436 4.000% | -393,564 (-25.15%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners II, L.P. | 6,351,531 5.600% | 6,351,531 (New Position) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners II, L.P. | 2,171,125 9.990% | 513,392 (+30.97%) | Filing History |
| 2022-11-14 4:11 pm Purchase | 2022-11-03 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners II, L.P. | 6,187,282 5.400% | 6,187,282 (New Position) | Filing History |
| 2022-10-28 4:05 pm Sale | 2022-10-25 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 2,982,528 5.400% | -5,899,349 (-66.42%) | Filing History |
| 2022-09-28 9:20 pm Purchase | 2022-09-26 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 8,881,877 16.000% | 3,016,717 (+51.43%) | Filing History |
| 2022-07-08 4:05 pm Purchase | 2022-04-06 | 13G | VistaGen Therapeutics, Inc. VTGN | Venrock Healthcare Capital Partners II, L.P. | 689,910 10.000% | 155,000 (+28.98%) | Filing History |
| 2022-06-23 4:05 pm Purchase | 2022-06-13 | 13G | Annexon, Inc. ANNX | Venrock Healthcare Capital Partners II, L.P. | 1,928,477 5.000% | 1,928,477 (New Position) | Filing History |
| 2022-06-23 06:02 am Purchase | 2022-06-13 | 13G | DBV Technologies S.A. DBVT | Venrock Healthcare Capital Partners II, L.P. | 470,141 9.900% | 470,141 (New Position) | Filing History |
| 2022-06-06 5:31 pm Purchase | 2022-06-01 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 5,865,160 10.600% | 2,370,309 (+67.82%) | Filing History |
| 2022-05-27 4:05 pm Purchase | 2022-05-17 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% | 2,820,501 (New Position) | Filing History |
| 2022-05-25 5:23 pm Purchase | 2022-05-15 | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners II, L.P. | 1,657,733 9.990% | 1,657,733 (New Position) | Filing History |
| 2022-05-23 4:30 pm Purchase | 2022-05-12 | 13G | Akouos, Inc. AKUS | Venrock Healthcare Capital Partners II, L.P. | 2,391,545 6.900% | 2,391,545 (New Position) | Filing History |
| 2022-04-29 4:05 pm Purchase | 2022-04-19 | 13G | Inozyme Pharma, Inc. INZY | Venrock Healthcare Capital Partners II, L.P. | 4,065,000 9.800% | 4,065,000 (New Position) | Filing History |
| 2022-04-22 4:05 pm Purchase | 2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA | Venrock Healthcare Capital Partners II, L.P. | 3,433,050 9.999% | 3,433,050 (New Position) | Filing History |